HSBC Holdings’s Upstream Bio UPB Stock Holding History
Bought
Maintained
Sold
Other funds holding UPB
HSBC Holdings's UPB Position: Q3 2026 in Review
HSBC Holdings increased its Upstream Bio (UPB) stake by 655% in Q3 2026, buying an estimated $463K and bringing the position to 81,500 shares worth $432K. The position accounts for ﹤0.01% of the portfolio, ranked #2341.
HSBC Holdings first reported a position in UPB in Q1 2026 and has held it in 3 quarters since. The position peaked at $5.76M in Q1 2026. 135 funds tracked by Wall St. Rank hold UPB as of Q3 2026.
- HSBC Holdings held 81,500 shares of Upstream Bio worth $432K as of Q3 2026.
- HSBC Holdings bought 70,707 Upstream Bio shares in Q3 2026, an estimated $463K.
- Upstream Bio made up ﹤0.01% of HSBC Holdings's portfolio in Q3 2026, its #2341 holding.
- HSBC Holdings first reported a position in Upstream Bio in Q1 2026 and has held it in 3 quarters since.
- HSBC Holdings's Upstream Bio position peaked at $5.76M in Q1 2026.
- 135 funds tracked by Wall St. Rank held Upstream Bio as of Q3 2026.
Based on HSBC Holdings's 13F filing for Q3 2026, filed 16 Nov 2026.